Invitae (NVTAQ)
(Delayed Data from OTC)
$0.00 USD
0.00 (-30.00%)
Updated Jul 12, 2024 03:52 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NVTAQ 0.00 0.00(-30.00%)
Will NVTAQ be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for NVTAQ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVTAQ
Phreesia (PHR) Reports Q1 Loss, Tops Revenue Estimates
Olink Holding AB (publ) Sponsored ADR (OLK) Reports Q1 Loss, Lags Revenue Estimates
NVTAQ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates
Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates
Other News for NVTAQ
Invitaeās April 2024 Bankruptcy Report Warns Investors
New Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered by Clinical Guidelines
Invitae Receives Court Approval for Sale to Labcorp
US Bankruptcy Court approves Invitae sale to Labcorp
Invitae Nears Asset Sale to Labcorp Amid Bankruptcy Process